Elizabeth Gabitzsch Email

SVP, Product Development & Vaccine Programs . ImmunityBio

Current Roles

Employees:
655
Revenue:
$1.5M
About
Leading late-stage immunotherapy company harnessing immunogenic cell death by orchestrating both the innate (NK) and adaptive (T Cell) immune system through first-in-class immunological platforms. ImmunityBio (formerly NantCell) develops novel combinations of chemo-immune sensitizers, cell therapies, cytokines, vaccines, neoepitopes, and monoclonal antibody immunotherapies to orchestrate the NK and T Cell response for cancer and infectious diseases.
ImmunityBio Address
9920 Jefferson Blvd
Culver City, CA
United States
ImmunityBio Email

Past Companies

ImmunityBio, Inc.Vice President, Process And Product Development, Vaccines

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.